Hippocampal transverse relaxation times in patients with Alzheimer disease

Radiology

Volumn 205, Issue 1, 1997, Pages 197-201

  Campeau, Norbert G ^a   Petersen, Ronald C ^a   Felmlee, Joel P ^a   O'Brien, Peter C ^a   Jack Jr , Clifford R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dementia; Hippocampus; Magnetic resonance (MR), relaxometry

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0030850328     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.205.1.9314985     Document Type: Article

References (27)

1. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988; 38:359-364.
2. Jack CR, Petersen RC, O'Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42:183-188.
3. George AE, DeLeon MJ, Stylopoulos LA, et al. CT diagnostic features of Alzheimer's disease: importance of the choroidal/hippocampal fissure complex. AJNR 1990; 11: 101-107.
4. DeLeon MJ, Convit A, DeSanti S, et al. The hippocampus in aging and Alzheimer's disease. Neuroimaging Clin North Am 1995; 5:1-17.
5. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225:1168-1170.
6. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970; 11:205-242.
7. Fazekas F, Chawlug JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR 1987; 149:351-356.
8. Kirsch SJ, Roland WJ, Butcher LL, Beatty J. Prolongation of magnetic resonance T2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease (letter). Neuroscience 1992; 134:187-190.
9. Laakso MP, Partanen K, Soininen H, et al. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment. Neurobiol Aging 1996; 17:1-5.
10. Petersen RC, Kokmen E, Tangalos E, Ivnik RJ, Kurland LT. Mayo Clinic Alzheimer's Disease Patient Registry. Aging 1990; 2:408-415.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
12. Grunewald RA, Jackson GD, Connelly A, Duncan JS. MR detection of hippocampal disease in epilepsy: factors influencing T2 relaxation time. AJNR 1994; 15:1149-1156.
13. Robb RA, Hanson DP, Karwoski RA, Larson AG, Workman EL, Stacy MC. ANALYZE: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. Comput Med Imaging Graph 1989; 13:433-454.
14. Berg L. Mild senile dementia of the Alzheimer type: clinical dementia rating (CDR). Psychopharmacol Bull 1988; 24:637-639.
15. Poon CS, Szumowski J, Plewes DB, Ashby P, Henkelman RM. Fat/water quantitation and differential relaxation time measurement using chemical shift imaging technique. Magn Reson Imaging 1989; 7:369-382.
16. Pitkanen A, Laakso M, Kalviainen R, et al. Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology 1996; 46: 1724-1730.
17. Huesgen CT, Burger PC, Grain BJ, Johnson GA. In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 1993; 43:145-152.
18. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41:51-54.
19. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer's disease. AJNR 1994; 15:927-937.
20. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect 1995; 9:73-86.
21. Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994; 44:1660-1668.
22. Pearlson G, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992; 49:402-408.
23. Killany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993; 50:949-954.
24. Convit A, deLeon MJ, Golomb J, et al. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q 1993; 64:371-387.
25. Convit A, deLeon MH, Tarshish C, et al. Hippocampal volume losses in minimally impaired elderly (letter). Lancet 1995; 345: 266.
26. Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of hippocampal formation. Radiology 1990; 175: 423-429.
27. Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993; 43:1793-1799.